clofazimine and linezolid

clofazimine has been researched along with linezolid in 47 studies

Research

Studies (47)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (2.13)	29.6817
2010's	26 (55.32)	24.3611
2020's	20 (42.55)	2.80

Authors

Authors	Studies
Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Biava, M; Cocozza, M; Consalvi, S; Poce, G	1
Ekins, S; Kyaw Zin, PP; Makarov, V; Reynolds, RC; Salina, E	1
Castagnolo, D; Denny, WA; Dos Santos, JL; Fernandes, GFS; Thompson, AM	1
Alffenaar, JW; Bolhuis, MS; Kosterink, JG; Uges, DR; van Altena, R; van der Werf, TS	1
Cole, ST; Dhar, N; Hartkoorn, RC; Mendoza-Losana, A; Sala, C; Zhang, M	1
Chang, KC; Leung, CC; Tam, CM; Yew, WW	1
Kim, DS; Kim, WS; Lee, SD; Lyu, J; Shim, TS; Yoo, JW	1
Jo, KW; Kim, DS; Kim, S; Kim, WS; Lee, JY; Lee, SD; Shim, TS	1
Caminero, JA; Scardigli, A	1
Achar, J; Bobokhojaev, OI; du Cros, P; Dusmatova, Z; Quinnell, S; Seddon, JA; Swaminathan, A	1
Cirillo, DM; Hoffner, S; Ismail, NA; Kaniga, K; Kaur, D; Lounis, N; Metchock, B; Pfyffer, GE; Venter, A	1
Blackmore, T; McNaughton, A; McNaughton, H	1
Ahuja, S; Benedetti, A; Cox, H; Fox, GJ; Koh, WJ; Menzies, D; Pasvol, G; Viiklepp, P	1
Akkerman, O; Aleksa, A; Alffenaar, JW; Amale, R; Artsukevich, J; Belilovski, E; Borisov, SE; Bruchfeld, J; Caminero, JA; Carpena Martinez, I; Centis, R; Codecasa, L; D'Ambrosio, L; Dalcolmo, M; Davies Forsman, L; Denholm, J; Dheda, K; Douglas, P; Duarte, R; Enwerem, M; Esmail, A; Fadul, M; Filippov, A; Gaga, M; Ganatra, S; Garcia-Fuertes, JA; García-García, JM; González Montaner, P; Gualano, G; Jonsson, J; Kunst, H; Lau, JS; Lazaro Mastrapa, B; Manga, S; Manika, K; Maryandyshev, A; Migliori, GB; Mullerpattan, J; Oelofse, S; Ortelli, M; Palmero, DJ; Palmieri, F; Papalia, A; Papavasileiou, A; Payen, MC; Pontali, E; Robalo Cordeiro, C; Romero Leyet, R; Saderi, L; Sadutshang, TD; Sanukevich, T; Skrahina, A; Solodovnikova, V; Sotgiu, G; Spanevello, A; Teran Troya, JL; Tiberi, S; Topgyal, S; Toscanini, F; Tramontana, AR; Udwadia, ZF; Viggiani, P; White, V; Zumla, A	1
Caminero, JA; Migliori, GB; Piubello, A; Scardigli, A	1
Chen, HC; Huang, CC; Huang, WC; Wu, MF	1
Dong, L; Fu, Y; Huang, H; Huo, F; Jing, W; Li, Y; Ma, Y; Pang, Y; Zhao, L; Zong, Z	1
Arvidsson, PI; Baijnath, S; Govender, T; Kruger, HG; Moodley, C; Naicker, T; Ngcobo, B; Pym, A; Singh, SD	1
Akkerman, OW; Bathoorn, E; de Lange, WCM; Lokate, M; Louka, C; Pournaras, S; Ravensbergen, SJ; Stienstra, Y; van der Werf, TS	1
Borroni, E; Cirillo, DM; Crook, DW; Cugnata, F; Davies, TJ; Fowler, PW; Gibertoni Cruz, AL; Grazian, C; Hoosdally, SJ; Peto, TEA; Rancoita, PMV; Walker, TM	1
Ismail, N; Ismail, NA; Omar, SV; Peters, RPH	1
Ahmad, N; Ahuja, SD; Akkerman, OW; Alffenaar, JC; Anderson, LF; Baghaei, P; Bang, D; Barry, PM; Bastos, ML; Behera, D; Benedetti, A; Bisson, GP; Boeree, MJ; Bonnet, M; Brode, SK; Brust, JCM; Cai, Y; Caumes, E; Cegielski, JP; Centis, R; Chan, ED; Chan, PC; Chang, KC; Charles, M; Cirule, A; D'Ambrosio, L; Dalcolmo, MP; de Vries, G; Dheda, K; Esmail, A; Flood, J; Fox, GJ; Fréchet-Jachym, M; Fregona, G; Gayoso, R; Gegia, M; Gler, MT; Gu, S; Guglielmetti, L; Holtz, TH; Hughes, J; Isaakidis, P; Jarlsberg, L; Kempker, RR; Keshavjee, S; Khan, FA; Kipiani, M; Koenig, SP; Koh, WJ; Kritski, A; Kuksa, L; Kvasnovsky, CL; Kwak, N; Lan, Z; Lange, C; Laniado-Laborín, R; Lee, M; Leimane, V; Leung, CC; Leung, EC; Li, PZ; Lowenthal, P; Maciel, EL; Marks, SM; Mase, S; Mbuagbaw, L; Menzies, D; Migliori, GB; Milanov, V; Miller, AC; Mitnick, CD; Modongo, C; Mohr, E; Monedero, I; Nahid, P; Ndjeka, N; O'Donnell, MR; Padayatchi, N; Palmero, D; Pape, JW; Podewils, LJ; Reynolds, I; Riekstina, V; Robert, J; Rodriguez, M; Schnippel, K; Seaworth, B; Seung, KJ; Shim, TS; Singla, R; Smith, SE; Sotgiu, G; Sukhbaatar, G; Tabarsi, P; Tiberi, S; Trajman, A; Trieu, L; Udwadia, ZF; van der Werf, TS; Veziris, N; Viiklepp, P; Vilbrun, SC; Walsh, K; Westenhouse, J; Yew, WW; Yim, JJ; Zetola, NM; Zignol, M	1
Bantubani, N; Chotoo, S; Conradie, F; Enwerem, M; Ferreira, H; Hughes, J; Ismail, N; Maartens, G; Master, I; Meintjes, G; Mohr, E; Ndjeka, N; Padanilam, X; Romero, R; Schnippel, K; Singh, N; Te Riele, J; Variava, E	1
Karstaedt, AS; Louw, R; Nkurunziza, J; Padanilam, X	1
Laughon, BE; Lee, SFK; Lipman, M; McHugh, TD	1
Chu, N; Dai, G; Dong, L; Huang, H; Huo, F; Jing, W; Li, Y; Lu, J; Pang, Y; Zong, Z	1
Khalid, UK; Kumar Verma, A; Mathuria, KK; Munjal, S; Myneedu, VP; Puri, MM; Sarin, R; Singla, N; Singla, R; Vohra, V	1
Chiang, CY; de Jong, BC; Decroo, T; Ortuno-Gutierrez, N; Piubello, A; Rieder, HL; Schwoebel, V; Tahseen, S; Trébucq, A; Van Deun, A	1
Ahmad, N; Baghaei, P; Barkane, L; Benedetti, A; Brode, SK; Brust, JCM; Campbell, JR; Chang, VWL; Falzon, D; Guglielmetti, L; Isaakidis, P; Kempker, RR; Kipiani, M; Kuksa, L; Lan, Z; Lange, C; Laniado-Laborín, R; Menzies, D; Nahid, P; Rodrigues, D; Singla, R; Udwadia, ZF	1
Farhat, M; Kadura, S; King, N; Köser, CU; Nakhoul, M; Theron, G; Zhu, H	1
Dhamija, RK; Garg, D; Saroha, D; Singh, AK	1
E R, V; Keny, S; Lawande, D; Parrikar, A	1
Chaudhary, S; Garg, V; Maji, S; Singh, V	1
Giacani, L; Haynes, AM; Mayans, MV; Mitjà, O; Nieto, C; Pérez-Mañá, C; Quintó, L; Romeis, E; Ubals, M	1
Basdeo, SA; Cahill, C; Cox, DJ; Gogan, KM; Gordon, SV; Keane, J; O'Connell, F; O'Sullivan, J; Phelan, JJ	1
Alam, MS; Chiwala, G; Cook, GM; Hameed, HMA; Lu, Z; Maslov, DA; Tian, X; Wang, S; Yu, W; Yusuf, B; Zhang, T; Zhong, N	1
Alshaer, MH; Avaliani, T; Avaliani, Z; Bakuradze, T; Blumberg, HM; Collins, JM; Gujabidze, M; Kempker, RR; Kipiani, M; Peloquin, CA; Sabanadze, S; Smith, AGC	1
Almoslem, M; Drusano, GL; Duncanson, B; Kim, S; Louie, A; Myrick, J; Neely, M; Nole, J; Peloquin, CA; Scanga, CA; Schmidt, S; Yamada, W	1
Ahmed, S; Bastard, M; Franke, MF; Grium Tefera, D; Hewison, C; Holtzman, D; Huerga, H; Islam, S; Jacques Leblanc, G; Khan, PY; Khan, U; Kumsa, A; Lachenal, N; Leonovich, O; Mamsa, S; Manzur-Ul-Alam, M; Melikyan, N; Mitnick, CD; Myint, Z; Osso, E; Padayachee, S; Rafi Siddiqui, M; Rashitov, M; Rich, ML; Salahuddin, N; Salia, G; Sánchez, E; Serobyan, A; Seung, KJ; Varaine, F; Vetushko, D; Yeghiazaryan, L	1
Adam, I; Byabajungu, H; Guido, O; Joloba, ML; Kabahita, JM; Kabugo, J; Kakembo, FE; Kakooza, F; Kanyerezi, S; Kasule, GW; Lutaaya, P; Mboowa, G; Musisi, K; Nabisubi, P; Nakato, H; Namaganda, MM; Namutebi, J; Oola, D; Otim, J; Sserwadda, I	1
Chen, X; Ding, Y; Fu, L; Guo, S; Liu, H; Lu, Y; Wang, B; Wang, N; Zhang, W; Zhu, H	1
Anupurba, S; Banerjee, T; Gupta, A; Sharma, S; Singh, K	1
Garcia-Prats, AJ; Kaiser, B; Seddon, JA; Starke, JR; Waning, B	1
Fitzgibbon, MM; Flanagan, PR; Mok, S; Roycroft, E; Wagener, J	1
Ardizzoni, E; Atger, M; Austin, A; Baudin, E; Bekhit, M; Bektasov, S; Berikova, E; Bonnet, M; Caboclo, R; Chaudhry, M; Chavan, V; Cloez, S; Coit, J; Coutisson, S; Dakenova, Z; De Jong, BC; Delifer, C; Demaisons, S; Do, JM; Dos Santos Tozzi, D; Ducher, V; Ferlazzo, G; Gouillou, M; Guglielmetti, L; Khan, U; Khazhidinov, K; Kunda, M; Lachenal, N; LaHood, AN; Lecca, L; Mazmanian, M; McIlleron, H; Mitnick, CD; Moreau, M; Moschioni, M; Nahid, P; Osso, E; Oyewusi, L; Panda, S; Pâquet, A; Patil, SB; Pichon, L; Rich, ML; Rupasinghe, P; Salahuddin, N; Sanchez Garavito, E; Seung, KJ; Tamirat, M; Thuong Huu, P; Vallet, M; Varaine, F; Velásquez, GE; Yuya-Septoh, FJ	1

Reviews

9 review(s) available for clofazimine and linezolid

Article	Year
SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development. European journal of medicinal chemistry, 2014, Oct-30, Volume: 86 Topics: Animals; Antitubercular Agents; Humans; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis; Tuberculosis, Multidrug-Resistant	2014
Molecule Property Analyses of Active Compounds for Journal of medicinal chemistry, 2020, 09-10, Volume: 63, Issue:17 Topics: Antitubercular Agents; Bacterial Proteins; Drug Discovery; Drug Resistance, Bacterial; Humans; Mycobacterium tuberculosis; Nitroimidazoles; Nucleoside-Phosphate Kinase; Structure-Activity Relationship; Tuberculosis	2020
Tuberculosis Drug Discovery: Challenges and New Horizons. Journal of medicinal chemistry, 2022, 06-09, Volume: 65, Issue:11 Topics: Antitubercular Agents; COVID-19 Drug Treatment; Drug Discovery; Humans; Mycobacterium tuberculosis; Tuberculosis	2022
WHO group 5 drugs and difficult multidrug-resistant tuberculosis: a systematic review with cohort analysis and meta-analysis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:9 Topics: Acetamides; Adult; Antitubercular Agents; beta-Lactams; Clofazimine; Cohort Studies; Databases, Bibliographic; Female; Fluoroquinolones; Humans; Isoniazid; Linezolid; Macrolides; Male; Oxazolidinones; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2013
Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis. The European respiratory journal, 2017, Volume: 49, Issue:1 Topics: Adult; Amoxicillin; Antitubercular Agents; Clofazimine; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Linezolid; Logistic Models; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Oxazolidinones; Thioacetazone; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2017
Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet (London, England), 2018, 09-08, Volume: 392, Issue:10150 Topics: Amikacin; Antitubercular Agents; Capreomycin; Carbapenems; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Fluoroquinolones; Humans; Kanamycin; Levofloxacin; Linezolid; Moxifloxacin; Recurrence; Treatment Failure; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2018
New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease. Current opinion in pulmonary medicine, 2019, Volume: 25, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Liposomes; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Nitroimidazoles; Oxazoles	2019
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. The Lancet. Respiratory medicine, 2020, Volume: 8, Issue:4 Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Canada; Clofazimine; Diarylquinolines; Drug-Related Side Effects and Adverse Reactions; Female; Fluoroquinolones; Humans; Incidence; Linezolid; Male; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2020
Systematic review of mutations associated with resistance to the new and repurposed Mycobacterium tuberculosis drugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid. The Journal of antimicrobial chemotherapy, 2020, 08-01, Volume: 75, Issue:8 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Pharmaceutical Preparations; Tuberculosis, Multidrug-Resistant	2020

Trials

1 trial(s) available for clofazimine and linezolid

Article	Year
Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial. Trials, 2023, Nov-30, Volume: 24, Issue:1 Topics: Antitubercular Agents; Clinical Trials, Phase III as Topic; Clofazimine; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Linezolid; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant	2023

Article

Year

Evaluating newly approved drugs in combination regimens for multidrug-resistant tuberculosis with fluoroquinolone resistance (endTB-Q): study protocol for a multi-country randomized controlled trial.

Trials, 2023, Nov-30, Volume: 24, Issue:1

Topics: Antitubercular Agents; Clinical Trials, Phase III as Topic; Clofazimine; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Humans; Linezolid; Randomized Controlled Trials as Topic; Tuberculosis, Multidrug-Resistant

2023

Other Studies

37 other study(ies) available for clofazimine and linezolid

Article	Year
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:4 Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen	2007
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Clarithromycin significantly increases linezolid serum concentrations. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Acetamides; Adult; Chromatography, Liquid; Clarithromycin; Clofazimine; Cycloserine; Drug Interactions; Humans; Linezolid; Male; Oxazolidinones; Tandem Mass Spectrometry; Tuberculosis, Pulmonary	2010
Streptomycin-starved Mycobacterium tuberculosis 18b, a drug discovery tool for latent tuberculosis. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Acetamides; Amino Acid Sequence; Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Disease Models, Animal; Drug Discovery; Drugs, Investigational; Female; Genetic Engineering; Latent Tuberculosis; Linezolid; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Sequence Data; Mycobacterium tuberculosis; Oxazines; Oxazolidinones; Quinolines; Rifampin; Streptomycin; Structure-Activity Relationship; Xanthenes	2012
Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis [Correspondence]. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2013, Volume: 17, Issue:9 Topics: Acetamides; Adult; Aged; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Female; Humans; Linezolid; Logistic Models; Male; Middle Aged; Odds Ratio; Oxazolidinones; Risk Factors; Time Factors; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Young Adult	2013
Treatment outcomes of refractory MAC pulmonary disease treated with drugs with unclear efficacy. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2014, Volume: 20, Issue:10 Topics: Aged; Anti-Bacterial Agents; Clofazimine; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Linezolid; Lung Diseases; Male; Middle Aged; Moxifloxacin; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retreatment; Retrospective Studies; Rifabutin; Treatment Failure	2014
Classification of antituberculosis drugs: a new proposal based on the most recent evidence. The European respiratory journal, 2015, Volume: 46, Issue:4 Topics: Antitubercular Agents; Carbapenems; Clavulanic Acid; Clofazimine; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Humans; Infectious Disease Medicine; Linezolid; Nitroimidazoles; Oxazoles; Practice Guidelines as Topic; Tuberculosis, Multidrug-Resistant; World Health Organization	2015
Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:4 Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; Child; Child, Preschool; Clarithromycin; Clofazimine; Drug Combinations; Extensively Drug-Resistant Tuberculosis; Female; Follow-Up Studies; Humans; Linezolid; Male; Retrospective Studies; Sputum; Tajikistan; Treatment Outcome	2016
A Multilaboratory, Multicountry Study To Determine MIC Quality Control Ranges for Phenotypic Drug Susceptibility Testing of Selected First-Line Antituberculosis Drugs, Second-Line Injectables, Fluoroquinolones, Clofazimine, and Linezolid. Journal of clinical microbiology, 2016, Volume: 54, Issue:12 Topics: Antitubercular Agents; Clofazimine; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Quality Control; Tuberculosis, Multidrug-Resistant	2016
Comprehensive cost of treating one patient with MDR/pre-XDR-TB in Wellington, New Zealand. The European respiratory journal, 2016, Volume: 48, Issue:4 Topics: Adult; Amikacin; Aminosalicylic Acid; Anti-Bacterial Agents; Antitubercular Agents; Bronchoscopy; Clofazimine; Depression; Drug Costs; Emigrants and Immigrants; Ethambutol; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Health Care Costs; Humans; India; Isoniazid; Linezolid; Male; Mediastinum; Microbial Sensitivity Tests; Moxifloxacin; New Zealand; Pyrazinamide; Radiography, Thoracic; Rifampin; Schizophrenia, Paranoid; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pleural; Tuberculosis, Pulmonary	2016
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study. The European respiratory journal, 2017, Volume: 49, Issue:5 Topics: Adult; Antitubercular Agents; Carbapenems; Clofazimine; Cohort Studies; Diarylquinolines; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; HIV Infections; Humans; Linezolid; Male; Middle Aged; Patient Safety; Retrospective Studies; Sputum; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2017
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases. The European respiratory journal, 2017, Volume: 50, Issue:1 Topics: Aminosalicylic Acid; Antitubercular Agents; Carbapenems; Clofazimine; Communicable Disease Control; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Infectious Disease Medicine; Isoniazid; Linezolid; Mycobacterium tuberculosis; Treatment Outcome; Tuberculosis, Multidrug-Resistant; World Health Organization	2017
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2018, Volume: 51, Issue:5 Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin	2018
Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:10 Topics: Antitubercular Agents; Beijing; China; Clofazimine; Diarylquinolines; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Gatifloxacin; Humans; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mutation; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles	2017
Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model. International journal of antimicrobial agents, 2018, Volume: 51, Issue:1 Topics: Animals; Antitubercular Agents; Blood-Brain Barrier; Brain; Clofazimine; Disease Models, Animal; Female; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Tuberculosis	2018
Case Report: Carbapenemase-Producing Enterobacteriaceae in an Asylum Seeker with Multidrug-Resistant Tuberculosis. The American journal of tropical medicine and hygiene, 2018, Volume: 98, Issue:2 Topics: Adult; Amikacin; Carbapenem-Resistant Enterobacteriaceae; Clofazimine; Drug Monitoring; Humans; Linezolid; Male; Moxifloxacin; Netherlands; Prevalence; Prothionamide; Refugees; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Multidrug-Resistant	2018
Validating a 14-Drug Microtiter Plate Containing Bedaquiline and Delamanid for Large-Scale Research Susceptibility Testing of Mycobacterium tuberculosis. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:9 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Oxazoles; Reproducibility of Results; Tuberculosis; Tuberculosis, Multidrug-Resistant	2018
In vitro approaches for generation of Mycobacterium tuberculosis mutants resistant to bedaquiline, clofazimine or linezolid and identification of associated genetic variants. Journal of microbiological methods, 2018, Volume: 153 Topics: Antitubercular Agents; Bacteriological Techniques; Clofazimine; Diarylquinolines; Drug Resistance, Multiple, Bacterial; Genetic Variation; Genotype; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Phenotype; Tuberculosis, Multidrug-Resistant	2018
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen. The European respiratory journal, 2018, Volume: 52, Issue:6 Topics: Adult; Anti-HIV Agents; Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Resistance, Bacterial; Drug Therapy, Combination; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; HIV Infections; Humans; Levofloxacin; Linezolid; Male; Middle Aged; Poisson Distribution; South Africa; Treatment Outcome; Tuberculosis, Multidrug-Resistant	2018
Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018, 12-01, Volume: 22, Issue:12 Topics: Adolescent; Adult; Antitubercular Agents; Clofazimine; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; HIV Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; South Africa; Sputum; Treatment Outcome; Young Adult	2018
No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis. Diagnostic microbiology and infectious disease, 2019, Volume: 94, Issue:4 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis	2019
Initial experience of bedaquiline implementation under the National TB Programme at NITRD, Delhi, India. The Indian journal of tuberculosis, 2019, Volume: 66, Issue:1 Topics: Adult; Antitubercular Agents; Cardiotoxicity; Clofazimine; Cycloserine; Diarylquinolines; Drug Therapy, Combination; Electrocardiography; Ethionamide; Female; Humans; India; Linezolid; Male; Moxifloxacin; National Health Programs; Sputum; Time Factors; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary	2019
World Health Organization 2018 treatment guidelines for rifampicin-resistant tuberculosis: uncertainty, potential risks and the way forward. International journal of antimicrobial agents, 2020, Volume: 55, Issue:1 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Humans; Linezolid; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Pulmonary	2020
Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum. The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3 Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Clofazimine; Cycloserine; Deprescriptions; Diarylquinolines; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Kanamycin; Linezolid; Neural Conduction; Neurotoxicity Syndromes; Peripheral Nervous System Diseases; Pyrazinamide; Pyridoxine; Tuberculosis, Pulmonary	2020
Gitelman-like syndrome: A rare complication of using aminoglycosides in tuberculosis - A case report. The Indian journal of tuberculosis, 2020, Volume: 67, Issue:3 Topics: Alkalosis; Antitubercular Agents; Capreomycin; Clofazimine; Cycloserine; Deprescriptions; Ethionamide; Gitelman Syndrome; Humans; Hypocalcemia; Hypokalemia; Levofloxacin; Linezolid; Male; Middle Aged; Pyrazinamide; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Water-Electrolyte Imbalance	2020
Isolated multidrug-resistant tubercular tenosynovitis of the flexor tendon of the little finger. BMJ case reports, 2021, Feb-19, Volume: 14, Issue:2 Topics: Adult; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antitubercular Agents; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Resistance, Multiple; Ethambutol; Female; Fingers; Humans; Levofloxacin; Linezolid; Magnetic Resonance Imaging; Tendons; Tenosynovitis; Tuberculosis; Young Adult	2021
Efficacy of linezolid on Treponema pallidum, the syphilis agent: A preclinical study. EBioMedicine, 2021, Volume: 65 Topics: Animals; Area Under Curve; Clofazimine; Disease Models, Animal; Drug Evaluation, Preclinical; Linezolid; Male; Microbial Sensitivity Tests; Moxifloxacin; Penicillin G Benzathine; Rabbits; ROC Curve; Syphilis; Treponema pallidum	2021
The Iron Chelator Desferrioxamine Increases the Efficacy of Bedaquiline in Primary Human Macrophages Infected with BCG. International journal of molecular sciences, 2021, Mar-13, Volume: 22, Issue:6 Topics: Amikacin; Antitubercular Agents; Bacterial Load; Cell Survival; Clofazimine; Cycloserine; Deferoxamine; Diarylquinolines; Drug Resistance, Bacterial; Drug Synergism; Gene Expression; Humans; Interferon-gamma; Interleukin-1beta; Interleukin-6; Iron; Iron Chelating Agents; Linezolid; Macrophages; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium bovis; Primary Cell Culture; Pyrazinamide	2021
Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine, and Linezolid in a Murine Model of Tuberculosis. Antimicrobial agents and chemotherapy, 2021, 09-17, Volume: 65, Issue:10 Topics: Animals; Antitubercular Agents; Clofazimine; Disease Models, Animal; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Tuberculosis	2021
Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 09-10, Volume: 75, Issue:4 Topics: Antitubercular Agents; Clofazimine; Cycloserine; Humans; Linezolid; Mycobacterium tuberculosis; Tuberculosis, Meningeal	2022
Evaluating the effect of clofazimine against Mycobacterium tuberculosis given alone or in combination with pretomanid, bedaquiline or linezolid. International journal of antimicrobial agents, 2022, Volume: 59, Issue:2 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Nitroimidazoles; Tuberculosis, Multidrug-Resistant	2022
Safety and Effectiveness Outcomes From a 14-Country Cohort of Patients With Multi-Drug Resistant Tuberculosis Treated Concomitantly With Bedaquiline, Delamanid, and Other Second-Line Drugs. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-12, Volume: 75, Issue:8 Topics: Antitubercular Agents; Clofazimine; Cohort Studies; Diarylquinolines; Electrolytes; Fluoroquinolones; Humans; Linezolid; Nitroimidazoles; Oxazoles; Prospective Studies; Rifampin; Tuberculosis, Multidrug-Resistant	2022
First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda. Antimicrobial resistance and infection control, 2022, 05-12, Volume: 11, Issue:1 Topics: Adult; Antitubercular Agents; Clofazimine; Diarylquinolines; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rifampin; Tuberculosis, Multidrug-Resistant; Uganda	2022
Superior Efficacy of a TBI-166, Bedaquiline, and Pyrazinamide Combination Regimen in a Murine Model of Tuberculosis. Antimicrobial agents and chemotherapy, 2022, 09-20, Volume: 66, Issue:9 Topics: Animals; Antitubercular Agents; Clofazimine; Diarylquinolines; Disease Models, Animal; Isoniazid; Linezolid; Mice; Mice, Inbred BALB C; Mycobacterium tuberculosis; Pyrazinamide; Rifampin; Tuberculosis; Tuberculosis, Multidrug-Resistant	2022
Mutation detection and minimum inhibitory concentration determination against linezolid and clofazimine in confirmed XDR-TB clinical isolates. BMC microbiology, 2022, 10-03, Volume: 22, Issue:1 Topics: Agar; Antitubercular Agents; Clofazimine; Cytosine; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Thymine; Tuberculosis, Multidrug-Resistant	2022
New Drugs and Regimens for Tuberculosis Disease Treatment in Children and Adolescents. Journal of the Pediatric Infectious Diseases Society, 2022, Oct-31, Volume: 11, Issue:Supplement Topics: Adolescent; Antitubercular Agents; Clofazimine; Humans; Linezolid; Tuberculosis; Tuberculosis, Multidrug-Resistant	2022
Investigation of genomic mutations and their association with phenotypic resistance to new and repurposed drugs in Mycobacterium tuberculosis complex clinical isolates. The Journal of antimicrobial chemotherapy, 2023, 11-06, Volume: 78, Issue:11 Topics: Antitubercular Agents; Clofazimine; Diarylquinolines; Genomics; Humans; Linezolid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Tuberculosis, Multidrug-Resistant	2023